BlackRock
KURA icon

BlackRock’s Kura Oncology KURA Stock Holding History

BlackRock’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115M Buy
10,509,233
+871,702
+9% +$8.22M ﹤0.01% 2143
2026
Q1 		$78.4M Buy
9,637,531
+626,738
+7% +$5.38M ﹤0.01% 2255
2025
Q4 		$93.6M Sell
9,010,793
-504,342
-5% -$5.29M ﹤0.01% 2141
2025
Q3 		$84.2M Buy
9,515,135
+44,802
+0.5% +$319K ﹤0.01% 2208
2025
Q2 		$54.6M Buy
9,470,333
+1,292,687
+16% +$7.92M ﹤0.01% 2401
2025
Q1 		$54M Buy
8,177,646
+243,542
+3% +$1.9M ﹤0.01% 2336
2024
Q4 		$69.1M Buy
7,934,104
+778,687
+11% +$11.2M ﹤0.01% 2275
2024
Q3 		$140M Buy
7,155,417
+189,611
+3% +$3.84M ﹤0.01% 1881
2024
Q2 		$143M Buy
6,965,806
+66,437
+1% +$1.37M ﹤0.01% 1818
2024
Q1 		$147M Sell
6,899,369
-416,278
-6% -$8.09M ﹤0.01% 1832
2023
Q4 		$105M Buy
7,315,647
+394,602
+6% +$3.88M ﹤0.01% 2044
2023
Q3 		$63.1M Buy
6,921,045
+763,643
+12% +$7.75M ﹤0.01% 2264
2023
Q2 		$65.1M Buy
6,157,402
+788,095
+15% +$9.32M ﹤0.01% 2321
2023
Q1 		$65.7M Buy
5,369,307
+206,471
+4% +$2.58M ﹤0.01% 2274
2022
Q4 		$64.1M Buy
5,162,836
+283,528
+6% +$4.12M ﹤0.01% 2299
2022
Q3 		$66.7M Sell
4,879,308
-82,781
-2% -$1.28M ﹤0.01% 2241
2022
Q2 		$91M Buy
4,962,089
+14,744
+0.3% +$212K ﹤0.01% 2076
2022
Q1 		$79.6M Sell
4,947,345
-147,681
-3% -$2.13M ﹤0.01% 2282
2021
Q4 		$71.3M Buy
5,095,026
+93,610
+2% +$1.52M ﹤0.01% 2426
2021
Q3 		$93.7M Buy
5,001,416
+39,035
+0.8% +$736K ﹤0.01% 2261
2021
Q2 		$103M Sell
4,962,381
-261,165
-5% -$6.48M ﹤0.01% 2222
2021
Q1 		$148M Buy
5,223,546
+291,590
+6% +$9.23M ﹤0.01% 1939
2020
Q4 		$161M Buy
4,931,956
+547,852
+12% +$19.3M 0.01% 1773
2020
Q3 		$134M Buy
4,384,104
+46,592
+1% +$1.03M 0.01% 1693
2020
Q2 		$70.7M Buy
4,337,512
+1,389,746
+47% +$20M ﹤0.01% 2061
2020
Q1 		$29.3M Sell
2,947,766
-45,986
-2% -$526K ﹤0.01% 2396
2019
Q4 		$41.2M Buy
2,993,752
+21,563
+0.7% +$320K ﹤0.01% 2486
2019
Q3 		$45.1M Buy
2,972,189
+565,151
+23% +$10.1M ﹤0.01% 2357
2019
Q2 		$47.4M Buy
2,407,038
+61,255
+3% +$1.02M ﹤0.01% 2346
2019
Q1 		$38.9M Sell
2,345,783
-64,196
-3% -$989K ﹤0.01% 2406
2018
Q4 		$33.8M Buy
2,409,979
+13,842
+0.6% +$183K ﹤0.01% 2450
2018
Q3 		$41.9M Buy
2,396,137
+393,872
+20% +$7.55M ﹤0.01% 2476
2018
Q2 		$36.4M Buy
2,002,265
+406,963
+26% +$6.89M ﹤0.01% 2529
2018
Q1 		$29.9M Buy
1,595,302
+70,485
+5% +$1.37M ﹤0.01% 2543
2017
Q4 		$23.3M Buy
1,524,817
+502,296
+49% +$7.4M ﹤0.01% 2696
2017
Q3 		$15.3M Buy
1,022,521
+427,626
+72% +$4.01M ﹤0.01% 2940
2017
Q2 		$5.53M Buy
594,895
+555,938
+1,427% +$5.06M ﹤0.01% 3449
2017
Q1 		$343K Buy
+38,957
New +$286K ﹤0.01% 4067

Other funds holding KURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

BlackRock's KURA Position: Q2 2026 in Review

BlackRock increased its Kura Oncology (KURA) stake by 9% in Q2 2026, buying an estimated $8.22M and bringing the position to 10,509,233 shares worth $115M. The position accounts for ﹤0.01% of the portfolio, ranked #2143.

BlackRock first reported a position in KURA in Q1 2017 and has held it in 38 quarters since. The position peaked at $161M in Q4 2020. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • BlackRock held 10,509,233 shares of Kura Oncology worth $115M as of Q2 2026.
  • BlackRock bought 871,702 Kura Oncology shares in Q2 2026, an estimated $8.22M.
  • Kura Oncology made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2143 holding.
  • BlackRock first reported a position in Kura Oncology in Q1 2017 and has held it in 38 quarters since.
  • BlackRock's Kura Oncology position peaked at $161M in Q4 2020.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.